Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027; successor search launched

Jazz Pharmaceuticals plc

Executive Vice President and Chief Commercial Officer Samantha Pearce notified Jazz on Oct 6, 2026 of her intent to retire.
Retirement takes effect upon the earlier of the selection and appointment of her successor or June 30, 2027.
Jazz plans a formal search for a new Chief Commercial Officer, considering both internal and external candidates.
No successor has been named; Pearce continues as CCO during the transition.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Samantha Pearce

Executive Vice President, Chief Commercial Officer

JAZZ · Jazz Pharmaceuticals plc

Filed: October 9, 2026, 9:02 AM ET

On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Samantha Pearce departed as Executive Vice President, Chief Commercial Officer at Jazz Pharmaceuticals plc.

Action: retire
Role: Executive Vice President, Chief Commercial Officer

Exact text from the filing

On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.

View on SEC.gov

Jazz Pharmaceuticals plc filing history →

Source: SEC EDGAR

accession 0001628280-26-065497

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.